Binovi Technologies (Binovi Technologies) Debt-to-Revenue : N/A (As of Feb. 2022)

View and export this data going back to 2012. Start your Free Trial

What is Binovi Technologies Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Binovi Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2022 was $0.68 Mil. Binovi Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Feb. 2022 was $0.03 Mil. Binovi Technologies's annualized Revenue for the quarter that ended in Feb. 2022 was $-0.23 Mil. Binovi Technologies's annualized Debt-to-Revenue for the quarter that ended in Feb. 2022 was -3.10.

Binovi Technologies Debt-to-Revenue Historical Data

The historical data trend for Binovi Technologies's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binovi Technologies Debt-to-Revenue Chart

Binovi Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Debt-to-Revenue

Get a 7-Day Free Trial

0.15

0.10

4.84

Binovi Technologies Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Debt-to-Revenue	Get a 7-Day Free Trial															0.11	0.55	2.78	4.63	N/A

Competitive Comparison of Binovi Technologies's Debt-to-Revenue

For the Health Information Services subindustry, Binovi Technologies's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Binovi Technologies's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Binovi Technologies's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Binovi Technologies's Debt-to-Revenue falls into.

Binovi Technologies Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Binovi Technologies's Debt-to-Revenue for the fiscal year that ended in Feb. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.677	+	0.029)	/	0.146
	=	4.84

Binovi Technologies's annualized Debt-to-Revenue for the quarter that ended in Feb. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.677	+	0.029)	/	-0.228
	=	-3.10

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Feb. 2022) Revenue data.

Binovi Technologies Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Binovi Technologies's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Binovi Technologies (Binovi Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Binovi Technologies Corp (OTCPK:BNVIF) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7

Website

https://www.binovi.com

Binovi Technologies Corp is engaged in the development and commercialization of visual and neuro-cognitive processing products and manufacturing hardware and software for diagnosing and remediating visual perception disorders. The company has three geographical segments; the United States, Canada, and Other. it derives a majority of its revenue from the United States.